These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2363796)

  • 1. Effect of bismuth subcarbonate against Campylobacter pylori: do citrate ions improve antibacterial activity?
    Vogt K; Warrelmann M; Hahn H
    Zentralbl Bakteriol; 1990 May; 273(1):33-5. PubMed ID: 2363796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The minimum inhibitory concentrations of various bismuth salts against Campylobacter pylori.
    Vogt K; Warrelmann M; Hahn H
    Zentralbl Bakteriol; 1989 Sep; 271(3):304-10. PubMed ID: 2803458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fabrication of bismuth subcarbonate nanotube arrays from bismuth citrate.
    Chen R; So MH; Yang J; Deng F; Che CM; Sun H
    Chem Commun (Camb); 2006 Jun; (21):2265-7. PubMed ID: 16718324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro synergistic activity between bismuth subcitrate and various antimicrobial agents against Campylobacter pyloridis (C. pylori).
    Van Caekenberghe DL; Breyssens J
    Antimicrob Agents Chemother; 1987 Sep; 31(9):1429-30. PubMed ID: 3674850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of Campylobacter pyloridis to cimetidine, sucralfate, bismuth and sixteen antibiotics.
    Andreasen JJ; Andersen LP
    Acta Pathol Microbiol Immunol Scand B; 1987 Apr; 95(2):147-9. PubMed ID: 3591312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriostatic and bactericidal activity of ranitidine bismuth citrate in Helicobacter pylori clinical isolates.
    Alarcón T; Domingo D; Prieto N; López-Brea M
    Rev Esp Quimioter; 1999 Mar; 12(1):64-8. PubMed ID: 10209056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antimicrobial effects and metabolomic footprinting of carboxyl-capped bismuth nanoparticles against Helicobacter pylori.
    Nazari P; Dowlatabadi-Bazaz R; Mofid MR; Pourmand MR; Daryani NE; Faramarzi MA; Sepehrizadeh Z; Shahverdi AR
    Appl Biochem Biotechnol; 2014 Jan; 172(2):570-9. PubMed ID: 24104691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric anti-secretory, mucosal protective, anti-pepsin and anti-Helicobacter properties of ranitidine bismuth citrate.
    Stables R; Campbell CJ; Clayton NM; Clitherow JW; Grinham CJ; McColm AA; McLaren A; Trevethick MA
    Aliment Pharmacol Ther; 1993 Jun; 7(3):237-46. PubMed ID: 8364129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of the combination of ranitidine bismuth citrate and metronidazole against metronidazole-resistant Helicobacter pylori clinical isolates.
    López-Brea M; Domingo D; Sánchez I; Prieto N; Alarcón T
    J Antimicrob Chemother; 1998 Sep; 42(3):309-14. PubMed ID: 9786470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of amoxicillin, metronidazole, bismuth salicylate and six aminoglycosides against Helicobacter pylori.
    Brenciaglia MI; Fornara AM; Scaltrito MM; Braga PC; Dubini F
    J Chemother; 1996 Feb; 8(1):52-4. PubMed ID: 8835109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bactericidal activity of clarithromycin versus ampicillin alone and in combination with omeprazole and/or bismuth against clarithromycin-susceptible and clarithromycin-resistant strains of Helicobacter pylori.
    Coudron PE; Stratton CW
    Diagn Microbiol Infect Dis; 1998 Sep; 32(1):39-44. PubMed ID: 9791756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro synergy between ranitidine bismuth citrate and tetracycline or clarithromycin against resistant strains of Helicobacter pylori.
    Midolo PD; Lambert JR; Kerr TG; Tee W
    Eur J Clin Microbiol Infect Dis; 1999 Nov; 18(11):832-4. PubMed ID: 10614963
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhancement of bismuth antibacterial activity with lipophilic thiol chelators.
    Domenico P; Salo RJ; Novick SG; Schoch PE; Van Horn K; Cunha BA
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1697-703. PubMed ID: 9257744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metalloantibiotics: synthesis, characterization and antimicrobial evaluation of bismuth-fluoroquinolone complexes against Helicobacter pylori.
    Shaikh AR; Giridhar R; Megraud F; Yadav MR
    Acta Pharm; 2009 Sep; 59(3):259-71. PubMed ID: 19819823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of clinical isolates of Campylobacter pylori to 24 antimicrobial and anti-ulcer agents.
    Glupczynski Y; Delmee M; Bruck C; Labbe M; Avesani V; Burette A
    Eur J Epidemiol; 1988 Jun; 4(2):154-7. PubMed ID: 3402574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ranitidine bismuth citrate: a novel anti-ulcer agent with different physico-chemical characteristics and improved biological activity to a bismuth citrate-ranitidine admixture.
    McColm AA; McLaren A; Klinkert G; Francis MR; Connolly PC; Grinham CJ; Campbell CJ; Selway S; Williamson R
    Aliment Pharmacol Ther; 1996 Jun; 10(3):241-50. PubMed ID: 8791946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo susceptibility of Campylobacter pylori.
    Graham DY; Klein PD; Opekun AR; Smith KE; Polasani RR; Evans DJ; Evans DG; Alpert LC; Michaletz PA; Yoshimura HH
    Am J Gastroenterol; 1989 Mar; 84(3):233-8. PubMed ID: 2919580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial activities of nitrothiazole against Campylobacter jejuni and Campylobacter coli.
    Hof H; Rieffert M; Sticht-Groh V; Zak O; Schweizer EH
    Antimicrob Agents Chemother; 1984 Oct; 26(4):498-500. PubMed ID: 6517542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of ebrotidine, ranitidine, omeprazole, lansoprazole, and bismuth citrate against clinical isolates of Helicobacter pylori.
    Alarcón T; Domingo D; Sánchez I; Sanz JC; Martínez MJ; López-Brea M
    Eur J Clin Microbiol Infect Dis; 1998 Apr; 17(4):275-7. PubMed ID: 9707312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bismuth-norfloxacin complex: synthesis, physicochemical and antimicrobial evaluation.
    Shaikh AR; Giridhar R; Yadav MR
    Int J Pharm; 2007 Mar; 332(1-2):24-30. PubMed ID: 17174046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.